Abstract
Malaria is a lethal parasitosis, worldwide prevalence, and despite investments in the discovery of new drug candidates, a high mortality rate is still observed. In the search for new candidates as antimalarial drugs, the modulation of the glycolytic pathway has been investigated as an attractive target to inhibit the development of the parasite and the fight infection. The enolase enzyme …